Clinical Trials Directory

Trials / Completed

CompletedNCT04350489

IL-32 Isoforms Levels in GCF and Plasma of the Patients With Periodontitis

Increased Levels of Interleukin-32 Isoforms Alpha, Beta, Gamma, and Delta in the Gingival Crevicular Fluid and Plasma of the Patients With Periodontitis

Status
Completed
Phase
Study type
Observational
Enrollment
54 (actual)
Sponsor
Bulent Ecevit University · Academic / Other
Sex
All
Age
25 Years – 55 Years
Healthy volunteers
Accepted

Summary

Interleukin (IL)-32, which has been recently reported to be associated with periodontitis, has been suggested to have pleiotropic effect due to its 9 different isoforms. The aim of this study was to investigate the levels of IL-32α, IL-32β, IL-32γ, IL-32δ isoforms in gingival crevicular fluid (GCF) and plasma before and after nonsurgical periodontal treatment in patients with periodontitis (P).Twenty-seven P and 27 periodontally healthy controls (C) were recruited in this study. Periodontitis patients were performed nonsurgical periodontal treatment. GCF and plasma sampling and clinical periodontal parameters were evaluated before and 1 month after treatment. Enzyme-linked immunosorbent assay was used to analyze the levels of IL-32α, IL-32β, IL-32γ, IL-32δ isoforms in GCF and plasma samples.

Conditions

Interventions

TypeNameDescription
OTHERNon-surgical periodontal treatmentConventional non-surgical periodontal treatment were performed

Timeline

Start date
2017-10-01
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2020-04-17
Last updated
2020-04-20

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04350489. Inclusion in this directory is not an endorsement.